Clinical Trial Update: Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating epirubicin and tamoxifen with or without docetaxel in postmenopausal women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Epirubicin (epirubicin)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: International Collaborative Cancer Group | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN